BM Technologies Inc WT (BMTX.WT) had the highest return between October 21, 2024 and October 31, 2024 by a US stock, returning 1,281.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
BM Technologies Inc WT (BMTX.WT) | 10/21/2024 - 10/31/2024 | 1,281.38% |
Biofrontera Inc Warrants (BFRIW) | 10/21/2024 - 10/31/2024 | 893.72% |
Zoomcar (ZCARW) | 10/21/2024 - 10/31/2024 | 428.57% |
KWESST Micro Systems Inc Warrant (KWESW) | 10/21/2024 - 10/31/2024 | 344.78% |
Genprex (GNPX) | 10/21/2024 - 10/31/2024 | 309.09% |
Anghami Inc Warrants (ANGHW) | 10/21/2024 - 10/31/2024 | 257.27% |
Ensysce Biosciences (ENSC) | 10/21/2024 - 10/31/2024 | 214.07% |
Healthcare Triangle (HCTI) | 10/21/2024 - 10/31/2024 | 197.01% |
PAVmed Inc - Series Z (PAVMZ) | 10/21/2024 - 10/31/2024 | 181.56% |
Monopar Therapeutics (MNPR) | 10/21/2024 - 10/31/2024 | 167.83% |
GlycoMimetics (GLYC) | 10/21/2024 - 10/31/2024 | 156.72% |
Bone Biologics Corp Warrants (BBLGW) | 10/21/2024 - 10/31/2024 | 153.66% |
Coeptis Therapeutics (COEPW) | 10/21/2024 - 10/31/2024 | 119.51% |
Upexi (UPXI) | 10/21/2024 - 10/31/2024 | 118.99% |
XBP Europe (XBPEW) | 10/21/2024 - 10/31/2024 | 104.84% |
Nexalin Technology (NXLIW) | 10/21/2024 - 10/31/2024 | 103.63% |
DatChat Inc Series A Warrant (DATSW) | 10/21/2024 - 10/31/2024 | 102.99% |
Quince Therapeutics (QNCX) | 10/21/2024 - 10/31/2024 | 100% |
Nexalin Technology (NXL) | 10/21/2024 - 10/31/2024 | 97.62% |
SBC Medical (SBCWW) | 10/21/2024 - 10/31/2024 | 97.47% |
Vast Renewables Limited Ordinary Shares (VSTE) | 10/21/2024 - 10/31/2024 | 96.08% |
Binah Capital Group, Inc Warrants (BCGWW) | 10/21/2024 - 10/31/2024 | 93.25% |
Mingteng International Corporation Inc Ordinary Shares (MTEN) | 10/21/2024 - 10/31/2024 | 91.18% |
MIRA Pharmaceuticals, Inc Common Stock (MIRA) | 10/21/2024 - 10/31/2024 | 90.43% |
Helport AI Limited Warrants (HPAIW) | 10/21/2024 - 10/31/2024 | 88.89% |
